Cargando…
Rituximab for Steroid-Dependent Minimal Change Disease in Adults: Is It Time for a Change?
Minimal change disease (MCD) is a common cause of nephrotic syndrome, and steroid treatment is usually effective at the expense of adverse effects and frequent relapses. Rituximab, a monoclonal antibody against cluster of differentiation (CD)20 B-lymphocytes, leads to depletion of B-cells and has be...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933270/ https://www.ncbi.nlm.nih.gov/pubmed/35350528 http://dx.doi.org/10.7759/cureus.22313 |